SEC Form 4 · accession 0001104659-17-044099
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Z Sullivan-Bolyai
Officer — Chief Medical Officer
Period of report
Jul 6, 2017
Accepted (ET)
Jul 7, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 6, 2017 | A | 58,681 | $0.00 | A | 58,681 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.